BB Good human data, but mixed outcomes or surrogate markers. How we grade →IPD meta-analysis · 3 RCTs in adults with prediabetes
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes
A Pittas, T Kawahara, R Jorde, B Dawson-Hughes, E Vickery, E Angellotti et al. Annals of Internal Medicine. 2023.
- In plain language
- Pooled individual data from three placebo-controlled trials in prediabetes: vitamin D lowered new-onset diabetes by 15% (HR 0.85, 0.75 to 0.96), a 3.3 point lower absolute risk over 3 years, and raised the chance of returning to normal glucose by 30%. No clear differences in kidney stones, high calcium or death.
- Limits
- Only people with prediabetes; one of the three trials used eldecalcitol, an active vitamin D drug. The 76% lower risk at levels of 125 nmol/L or more compared groups by achieved level, not by randomization. Trials were not powered for safety. No funding source reported.
- Which of our grades it feeds
- AA Multiple randomized trials or meta-analyses, consistent results. How we grade →Science summary: Vitamin D: where it helps, and what the largest trials found
- Source
- doi.org/10.7326/M22-3018 · PubMed 36745886
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.